Global Cancer Testing/Screening Market Growth (Status and Outlook) 2022-2028

January 2022 | 89 pages | ID: G236DA07510EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Cancer Testing/Screening will have significant change from previous year. According to our (LP Information) latest study, the global Cancer Testing/Screening market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Cancer Testing/Screening market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Cancer Testing/Screening market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cancer Testing/Screening market, reaching US$ million by the year 2028. As for the Europe Cancer Testing/Screening landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Cancer Testing/Screening players cover Dias Orin, Epigenetics, Techlab, and Positive Bioscience, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Testing/Screening market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

• Magnetic Resonance Imaging (MRI)
• Human Papillomavirus (HPV) Testing
• Colonoscopy
• Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

• Lung Cancer
• Blood Cancer
• Bone Cancer
• Gall Bladder Cancer
• Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

• Dias Orin
• Epigenetics
• Techlab
• Positive Bioscience
• Genextropy
• M Genomics
• 20/20 GeneSystems
• AB SCIEX
• Abbott Laboratories

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Cancer Testing/Screening Market Size 2017-2028
  2.1.2 Cancer Testing/Screening Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Cancer Testing/Screening Segment by Type
  2.2.1 Magnetic Resonance Imaging (MRI)
  2.2.2 Human Papillomavirus (HPV) Testing
  2.2.3 Colonoscopy
  2.2.4 Others
2.3 Cancer Testing/Screening Market Size by Type
  2.3.1 Cancer Testing/Screening Market Size CAGR by Type (2017 VS 2022 VS 2028)
  2.3.2 Global Cancer Testing/Screening Market Size Market Share by Type (2017-2022)
2.4 Cancer Testing/Screening Segment by Application
  2.4.1 Lung Cancer
  2.4.2 Blood Cancer
  2.4.3 Bone Cancer
  2.4.4 Gall Bladder Cancer
  2.4.5 Others
2.5 Cancer Testing/Screening Market Size by Application
  2.5.1 Cancer Testing/Screening Market Size CAGR by Application (2017 VS 2022 VS 2028)
  2.5.2 Global Cancer Testing/Screening Market Size Market Share by Application (2017-2022)

3 CANCER TESTING/SCREENING MARKET SIZE BY PLAYER

3.1 Cancer Testing/Screening Market Size Market Share by Players
  3.1.1 Global Cancer Testing/Screening Revenue by Players (2020-2022)
  3.1.2 Global Cancer Testing/Screening Revenue Market Share by Players (2020-2022)
3.2 Global Cancer Testing/Screening Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CANCER TESTING/SCREENING BY REGIONS

4.1 Cancer Testing/Screening Market Size by Regions (2017-2022)
4.2 Americas Cancer Testing/Screening Market Size Growth (2017-2022)
4.3 APAC Cancer Testing/Screening Market Size Growth (2017-2022)
4.4 Europe Cancer Testing/Screening Market Size Growth (2017-2022)
4.5 Middle East & Africa Cancer Testing/Screening Market Size Growth (2017-2022)

5 AMERICAS

5.1 Americas Cancer Testing/Screening Market Size by Country (2017-2022)
5.2 Americas Cancer Testing/Screening Market Size by Type (2017-2022)
5.3 Americas Cancer Testing/Screening Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Cancer Testing/Screening Market Size by Region (2017-2022)
6.2 APAC Cancer Testing/Screening Market Size by Type (2017-2022)
6.3 APAC Cancer Testing/Screening Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Cancer Testing/Screening by Country (2017-2022)
7.2 Europe Cancer Testing/Screening Market Size by Type (2017-2022)
7.3 Europe Cancer Testing/Screening Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Cancer Testing/Screening by Region (2017-2022)
8.2 Middle East & Africa Cancer Testing/Screening Market Size by Type (2017-2022)
8.3 Middle East & Africa Cancer Testing/Screening Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CANCER TESTING/SCREENING MARKET FORECAST

10.1 Global Cancer Testing/Screening Forecast by Regions (2023-2028)
  10.1.1 Global Cancer Testing/Screening Forecast by Regions (2023-2028)
  10.1.2 Americas Cancer Testing/Screening Forecast
  10.1.3 APAC Cancer Testing/Screening Forecast
  10.1.4 Europe Cancer Testing/Screening Forecast
  10.1.5 Middle East & Africa Cancer Testing/Screening Forecast
10.2 Americas Cancer Testing/Screening Forecast by Country (2023-2028)
  10.2.1 United States Cancer Testing/Screening Market Forecast
  10.2.2 Canada Cancer Testing/Screening Market Forecast
  10.2.3 Mexico Cancer Testing/Screening Market Forecast
  10.2.4 Brazil Cancer Testing/Screening Market Forecast
10.3 APAC Cancer Testing/Screening Forecast by Region (2023-2028)
  10.3.1 China Cancer Testing/Screening Market Forecast
  10.3.2 Japan Cancer Testing/Screening Market Forecast
  10.3.3 Korea Cancer Testing/Screening Market Forecast
  10.3.4 Southeast Asia Cancer Testing/Screening Market Forecast
  10.3.5 India Cancer Testing/Screening Market Forecast
  10.3.6 Australia Cancer Testing/Screening Market Forecast
10.4 Europe Cancer Testing/Screening Forecast by Country (2023-2028)
  10.4.1 Germany Cancer Testing/Screening Market Forecast
  10.4.2 France Cancer Testing/Screening Market Forecast
  10.4.3 UK Cancer Testing/Screening Market Forecast
  10.4.4 Italy Cancer Testing/Screening Market Forecast
  10.4.5 Russia Cancer Testing/Screening Market Forecast
10.5 Middle East & Africa Cancer Testing/Screening Forecast by Region (2023-2028)
  10.5.1 Egypt Cancer Testing/Screening Market Forecast
  10.5.2 South Africa Cancer Testing/Screening Market Forecast
  10.5.3 Israel Cancer Testing/Screening Market Forecast
  10.5.4 Turkey Cancer Testing/Screening Market Forecast
  10.5.5 GCC Countries Cancer Testing/Screening Market Forecast
10.6 Global Cancer Testing/Screening Forecast by Type (2023-2028)
10.7 Global Cancer Testing/Screening Forecast by Application (2023-2028)

11 KEY PLAYERS ANALYSIS

11.1 Dias Orin
  11.1.1 Dias Orin Company Information
  11.1.2 Dias Orin Cancer Testing/Screening Product Offered
  11.1.3 Dias Orin Cancer Testing/Screening Revenue, Gross Margin and Market Share (2020-2022)
  11.1.4 Dias Orin Main Business Overview
  11.1.5 Dias Orin Latest Developments
11.2 Epigenetics
  11.2.1 Epigenetics Company Information
  11.2.2 Epigenetics Cancer Testing/Screening Product Offered
  11.2.3 Epigenetics Cancer Testing/Screening Revenue, Gross Margin and Market Share (2020-2022)
  11.2.4 Epigenetics Main Business Overview
  11.2.5 Epigenetics Latest Developments
11.3 Techlab
  11.3.1 Techlab Company Information
  11.3.2 Techlab Cancer Testing/Screening Product Offered
  11.3.3 Techlab Cancer Testing/Screening Revenue, Gross Margin and Market Share (2020-2022)
  11.3.4 Techlab Main Business Overview
  11.3.5 Techlab Latest Developments
11.4 Positive Bioscience
  11.4.1 Positive Bioscience Company Information
  11.4.2 Positive Bioscience Cancer Testing/Screening Product Offered
  11.4.3 Positive Bioscience Cancer Testing/Screening Revenue, Gross Margin and Market Share (2020-2022)
  11.4.4 Positive Bioscience Main Business Overview
  11.4.5 Positive Bioscience Latest Developments
11.5 Genextropy
  11.5.1 Genextropy Company Information
  11.5.2 Genextropy Cancer Testing/Screening Product Offered
  11.5.3 Genextropy Cancer Testing/Screening Revenue, Gross Margin and Market Share (2020-2022)
  11.5.4 Genextropy Main Business Overview
  11.5.5 Genextropy Latest Developments
11.6 M Genomics
  11.6.1 M Genomics Company Information
  11.6.2 M Genomics Cancer Testing/Screening Product Offered
  11.6.3 M Genomics Cancer Testing/Screening Revenue, Gross Margin and Market Share (2020-2022)
  11.6.4 M Genomics Main Business Overview
  11.6.5 M Genomics Latest Developments
11.7 20/20 GeneSystems
  11.7.1 20/20 GeneSystems Company Information
  11.7.2 20/20 GeneSystems Cancer Testing/Screening Product Offered
  11.7.3 20/20 GeneSystems Cancer Testing/Screening Revenue, Gross Margin and Market Share (2020-2022)
  11.7.4 20/20 GeneSystems Main Business Overview
  11.7.5 20/20 GeneSystems Latest Developments
11.8 AB SCIEX
  11.8.1 AB SCIEX Company Information
  11.8.2 AB SCIEX Cancer Testing/Screening Product Offered
  11.8.3 AB SCIEX Cancer Testing/Screening Revenue, Gross Margin and Market Share (2020-2022)
  11.8.4 AB SCIEX Main Business Overview
  11.8.5 AB SCIEX Latest Developments
11.9 Abbott Laboratories
  11.9.1 Abbott Laboratories Company Information
  11.9.2 Abbott Laboratories Cancer Testing/Screening Product Offered
  11.9.3 Abbott Laboratories Cancer Testing/Screening Revenue, Gross Margin and Market Share (2020-2022)
  11.9.4 Abbott Laboratories Main Business Overview
  11.9.5 Abbott Laboratories Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Cancer Testing/Screening Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Magnetic Resonance Imaging (MRI)
Table 3. Major Players of Human Papillomavirus (HPV) Testing
Table 4. Major Players of Colonoscopy
Table 5. Major Players of Others
Table 6. Cancer Testing/Screening Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Cancer Testing/Screening Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Cancer Testing/Screening Market Size Market Share by Type (2017-2022)
Table 9. Cancer Testing/Screening Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Cancer Testing/Screening Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Cancer Testing/Screening Market Size Market Share by Application (2017-2022)
Table 12. Global Cancer Testing/Screening Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Cancer Testing/Screening Revenue Market Share by Player (2020-2022)
Table 14. Cancer Testing/Screening Key Players Head office and Products Offered
Table 15. Cancer Testing/Screening Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Cancer Testing/Screening Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Cancer Testing/Screening Market Size Market Share by Regions (2017-2022)
Table 20. Americas Cancer Testing/Screening Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Cancer Testing/Screening Market Size Market Share by Country (2017-2022)
Table 22. Americas Cancer Testing/Screening Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Cancer Testing/Screening Market Size Market Share by Type (2017-2022)
Table 24. Americas Cancer Testing/Screening Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Cancer Testing/Screening Market Size Market Share by Application (2017-2022)
Table 26. APAC Cancer Testing/Screening Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Cancer Testing/Screening Market Size Market Share by Region (2017-2022)
Table 28. APAC Cancer Testing/Screening Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Cancer Testing/Screening Market Size Market Share by Type (2017-2022)
Table 30. APAC Cancer Testing/Screening Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Cancer Testing/Screening Market Size Market Share by Application (2017-2022)
Table 32. Europe Cancer Testing/Screening Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Cancer Testing/Screening Market Size Market Share by Country (2017-2022)
Table 34. Europe Cancer Testing/Screening Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Cancer Testing/Screening Market Size Market Share by Type (2017-2022)
Table 36. Europe Cancer Testing/Screening Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Cancer Testing/Screening Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Cancer Testing/Screening Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Cancer Testing/Screening Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Cancer Testing/Screening Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Cancer Testing/Screening Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Cancer Testing/Screening Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Cancer Testing/Screening Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Cancer Testing/Screening
Table 45. Key Market Challenges & Risks of Cancer Testing/Screening
Table 46. Key Industry Trends of Cancer Testing/Screening
Table 47. Global Cancer Testing/Screening Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Cancer Testing/Screening Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Cancer Testing/Screening Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Cancer Testing/Screening Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Cancer Testing/Screening Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Cancer Testing/Screening Market Size Market Share Forecast by Application (2023-2028)
Table 53. Dias Orin Details, Company Type, Cancer Testing/Screening Area Served and Its Competitors
Table 54. Dias Orin Cancer Testing/Screening Product Offered
Table 55. Dias Orin Cancer Testing/Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Dias Orin Main Business
Table 57. Dias Orin Latest Developments
Table 58. Epigenetics Details, Company Type, Cancer Testing/Screening Area Served and Its Competitors
Table 59. Epigenetics Cancer Testing/Screening Product Offered
Table 60. Epigenetics Main Business
Table 61. Epigenetics Cancer Testing/Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Epigenetics Latest Developments
Table 63. Techlab Details, Company Type, Cancer Testing/Screening Area Served and Its Competitors
Table 64. Techlab Cancer Testing/Screening Product Offered
Table 65. Techlab Main Business
Table 66. Techlab Cancer Testing/Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Techlab Latest Developments
Table 68. Positive Bioscience Details, Company Type, Cancer Testing/Screening Area Served and Its Competitors
Table 69. Positive Bioscience Cancer Testing/Screening Product Offered
Table 70. Positive Bioscience Main Business
Table 71. Positive Bioscience Cancer Testing/Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Positive Bioscience Latest Developments
Table 73. Genextropy Details, Company Type, Cancer Testing/Screening Area Served and Its Competitors
Table 74. Genextropy Cancer Testing/Screening Product Offered
Table 75. Genextropy Main Business
Table 76. Genextropy Cancer Testing/Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Genextropy Latest Developments
Table 78. M Genomics Details, Company Type, Cancer Testing/Screening Area Served and Its Competitors
Table 79. M Genomics Cancer Testing/Screening Product Offered
Table 80. M Genomics Main Business
Table 81. M Genomics Cancer Testing/Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. M Genomics Latest Developments
Table 83. 20/20 GeneSystems Details, Company Type, Cancer Testing/Screening Area Served and Its Competitors
Table 84. 20/20 GeneSystems Cancer Testing/Screening Product Offered
Table 85. 20/20 GeneSystems Main Business
Table 86. 20/20 GeneSystems Cancer Testing/Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. 20/20 GeneSystems Latest Developments
Table 88. AB SCIEX Details, Company Type, Cancer Testing/Screening Area Served and Its Competitors
Table 89. AB SCIEX Cancer Testing/Screening Product Offered
Table 90. AB SCIEX Main Business
Table 91. AB SCIEX Cancer Testing/Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. AB SCIEX Latest Developments
Table 93. Abbott Laboratories Details, Company Type, Cancer Testing/Screening Area Served and Its Competitors
Table 94. Abbott Laboratories Cancer Testing/Screening Product Offered
Table 95. Abbott Laboratories Main Business
Table 96. Abbott Laboratories Cancer Testing/Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. Abbott Laboratories Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Cancer Testing/Screening Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cancer Testing/Screening Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Cancer Testing/Screening Market Size Market Share by Type in 2021
Figure 7. Cancer Testing/Screening in Lung Cancer
Figure 8. Global Cancer Testing/Screening Market: Lung Cancer (2017-2022) & ($ Millions)
Figure 9. Cancer Testing/Screening in Blood Cancer
Figure 10. Global Cancer Testing/Screening Market: Blood Cancer (2017-2022) & ($ Millions)
Figure 11. Cancer Testing/Screening in Bone Cancer
Figure 12. Global Cancer Testing/Screening Market: Bone Cancer (2017-2022) & ($ Millions)
Figure 13. Cancer Testing/Screening in Gall Bladder Cancer
Figure 14. Global Cancer Testing/Screening Market: Gall Bladder Cancer (2017-2022) & ($ Millions)
Figure 15. Cancer Testing/Screening in Others
Figure 16. Global Cancer Testing/Screening Market: Others (2017-2022) & ($ Millions)
Figure 17. Global Cancer Testing/Screening Market Size Market Share by Application in 2021
Figure 18. Global Cancer Testing/Screening Revenue Market Share by Player in 2021
Figure 19. Global Cancer Testing/Screening Market Size Market Share by Regions (2017-2022)
Figure 20. Americas Cancer Testing/Screening Market Size 2017-2022 ($ Millions)
Figure 21. APAC Cancer Testing/Screening Market Size 2017-2022 ($ Millions)
Figure 22. Europe Cancer Testing/Screening Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa Cancer Testing/Screening Market Size 2017-2022 ($ Millions)
Figure 24. Americas Cancer Testing/Screening Value Market Share by Country in 2021
Figure 25. Americas Cancer Testing/Screening Consumption Market Share by Type in 2021
Figure 26. Americas Cancer Testing/Screening Market Size Market Share by Application in 2021
Figure 27. United States Cancer Testing/Screening Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada Cancer Testing/Screening Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico Cancer Testing/Screening Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil Cancer Testing/Screening Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC Cancer Testing/Screening Market Size Market Share by Region in 2021
Figure 32. APAC Cancer Testing/Screening Market Size Market Share by Application in 2021
Figure 33. China Cancer Testing/Screening Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan Cancer Testing/Screening Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea Cancer Testing/Screening Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia Cancer Testing/Screening Market Size Growth 2017-2022 ($ Millions)
Figure 37. India Cancer Testing/Screening Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia Cancer Testing/Screening Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe Cancer Testing/Screening Market Size Market Share by Country in 2021
Figure 40. Europe Cancer Testing/Screening Market Size Market Share by Type in 2021
Figure 41. Europe Cancer Testing/Screening Market Size Market Share by Application in 2021
Figure 42. Germany Cancer Testing/Screening Market Size Growth 2017-2022 ($ Millions)
Figure 43. France Cancer Testing/Screening Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK Cancer Testing/Screening Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy Cancer Testing/Screening Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia Cancer Testing/Screening Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Cancer Testing/Screening Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa Cancer Testing/Screening Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa Cancer Testing/Screening Market Size Market Share by Application in 2021
Figure 50. Egypt Cancer Testing/Screening Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa Cancer Testing/Screening Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel Cancer Testing/Screening Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey Cancer Testing/Screening Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country Cancer Testing/Screening Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas Cancer Testing/Screening Market Size 2023-2028 ($ Millions)
Figure 56. APAC Cancer Testing/Screening Market Size 2023-2028 ($ Millions)
Figure 57. Europe Cancer Testing/Screening Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa Cancer Testing/Screening Market Size 2023-2028 ($ Millions)
Figure 59. United States Cancer Testing/Screening Market Size 2023-2028 ($ Millions)
Figure 60. Canada Cancer Testing/Screening Market Size 2023-2028 ($ Millions)
Figure 61. Mexico Cancer Testing/Screening Market Size 2023-2028 ($ Millions)
Figure 62. Brazil Cancer Testing/Screening Market Size 2023-2028 ($ Millions)
Figure 63. China Cancer Testing/Screening Market Size 2023-2028 ($ Millions)
Figure 64. Japan Cancer Testing/Screening Market Size 2023-2028 ($ Millions)
Figure 65. Korea Cancer Testing/Screening Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia Cancer Testing/Screening Market Size 2023-2028 ($ Millions)
Figure 67. India Cancer Testing/Screening Market Size 2023-2028 ($ Millions)
Figure 68. Australia Cancer Testing/Screening Market Size 2023-2028 ($ Millions)
Figure 69. Germany Cancer Testing/Screening Market Size 2023-2028 ($ Millions)
Figure 70. France Cancer Testing/Screening Market Size 2023-2028 ($ Millions)
Figure 71. UK Cancer Testing/Screening Market Size 2023-2028 ($ Millions)
Figure 72. Italy Cancer Testing/Screening Market Size 2023-2028 ($ Millions)
Figure 73. Russia Cancer Testing/Screening Market Size 2023-2028 ($ Millions)
Figure 74. Spain Cancer Testing/Screening Market Size 2023-2028 ($ Millions)
Figure 75. Egypt Cancer Testing/Screening Market Size 2023-2028 ($ Millions)
Figure 76. South Africa Cancer Testing/Screening Market Size 2023-2028 ($ Millions)
Figure 77. Israel Cancer Testing/Screening Market Size 2023-2028 ($ Millions)
Figure 78. Turkey Cancer Testing/Screening Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries Cancer Testing/Screening Market Size 2023-2028 ($ Millions)